Health Care

Buy, Sell or Hold Healthcare Stock: AbbVie Inc. (NYSE:ABBV)

0 10

AbbVie Inc. (NYSE:ABBV) closed its last session at $63.34 The market capitalization of the company is $103.15B with an average Volume of 7.28 million shares. The stock currently has its 52-Week High range of $68.12 and 52-week low range of $45.45. The Price to Book (P/B) ratio stands at 18.29. The stock traded total quantity of 5.89 million shares.

Currently AbbVie Inc. (ABBV) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “11″ Analysts”. “1” rated “Sell” for the company. “9” said the company as a “Hold”. Overweight rating was given by “1” and Underweight rating was given by “0”.

Analysts are expecting that the company to achieve $71.46 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $90.00 however minimum price target advised by analysts is $49.00. The Median price target for the stock is measured at $71.50.

Presently, Analysts decided consensus EPS estimate of $1.20 for present quarter and one month ago projected EPS estimate was at $1.20. If we take a look at back 3 month ago, consensus EPS estimate was $1.20.

A current consensus EPS estimate for next quarter is at $1.19 and 3 month ago EPS forecast was $1.21. Have a look at back 1 month ago, consensus EPS forecast was seen at $1.20.

For current fiscal year, most recent EPS estimate is set at $4.80 based on Analyst consensus and three month ago consensus EPS opinions was at $4.76. During period one month ago, consensus EPS forecast was decided at $4.80.

A current consensus EPS projection for next fiscal year is observed at $5.65 and one month ago consensus EPS forecast was at $5.67. Take a look at back three month ago, consensus EPS estimate opinions was decided at $5.61 by analysts.

One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 12 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 8 advised the “Hold” rating about this stock. 1 revealed “Sell” signal and “Underweight” rating was declared by 0.

Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 12 said a “Buy Rating” and 0 announced “Overweight Rating”. 8 advised “Hold Rating” regarding the stock. 1 announced “Sell Rating” and 0 disclosed “Underweight Rating”.

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.